Physician

David Yhoshin Kim, M.D.

According to 2025 Medicare claims, David Kim, M.D. (NPI: 1972763530) practices ophthalmology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bergen, NJ. This provider's primary affiliated billing organization is ASSOCIATED RETINAL CONSULTANTS LLC (NPI: 1164578894; TIN: 208346981) and primary practice location at 07666-1704. Kim is affiliated with the Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Kim's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 964 traditional Medicare patients, billed 27,381 HCPCS/CPT codes, and received $3,840,654 in Medicare payments. The top billing code was J0177 (Injection, aflibercept hd, 1 mg). Part D data shows 430 prescription claims across 119 beneficiaries totaling $61,397 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 21 records totaling $350. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,591	23,506	$3,624,967
2016	1,483	23,883	$3,959,132
2017	1,365	23,278	$3,978,757
2018	1,661	26,115	$4,646,161
2019	1,230	21,868	$4,069,319
2020	1,059	15,746	$3,620,309
2021	1,109	17,140	$3,795,436
2022	1,009	16,339	$3,446,242
2023	1,065	24,950	$3,420,272
2024	964	27,381	$3,840,654

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	187	561	$47,882
2016	201	604	$45,239
2017	189	593	$58,598
2018	230	806	$97,751
2019	160	603	$89,460
2020	134	541	$77,811
2021	138	544	$75,636
2022	137	490	$83,569
2023	138	479	$73,065
2024	119	430	$61,397

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
J0177	Injection, aflibercept hd, 1 mg	209	6,032	$264
92014	Established patient complete exam of visual system	860	2,386	$104
67028	Injection of drug into eye	397	1,815	$101
92134	Imaging of retina	872	2,411	$36
92202	Extended exam of the back part of the eye with optic nerve drawing	735	1,935	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Restasis	Cyclosporine	17	810	$17,062
Lumigan	Bimatoprost	26	1,450	$13,264
Prolensa	Bromfenac Sodium	18	586	$6,166
Prednisolone Acetate	Prednisolone Acetate	66	2,482	$3,089
Ketorolac Tromethamine	Ketorolac Tromethamine	54	1,614	$1,262

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	21	$350	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David Yhoshin Kim, M.D.?

Tedicare shows public-source Medicare data for David Yhoshin Kim, M.D. (NPI 1972763530), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Yhoshin Kim, M.D. have ACO affiliation data?

David Yhoshin Kim, M.D. is shown with ACO affiliation data for Physician Leaders Direct Contracting Entity, LLC (REACH, ACO ID D0171) and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to David Yhoshin Kim, M.D.?

David Yhoshin Kim, M.D. is linked to ASSOCIATED RETINAL CONSULTANTS LLC (billing NPI 1164578894) in the available physician profile data.

Does David Yhoshin Kim, M.D. have Open Payments data?

David Yhoshin Kim, M.D. has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.